Dark

ICLR
Icon Plc
stock NASDAQ

At Close

Jan 14, 2026 3:59:55 PM EST

184.74USD+0.791%(+1.45)785,086

184.27Bid 184.57Ask 0.30Spread

Pre-market

Jan 12, 2026 9:03:30 AM EST

181.50USD-0.977%(-1.79)0

After-hours

Jan 14, 2026 4:00:30 PM EST

184.77USD+0.016%(+0.03)5,429

OverviewOptionsHistoricalExchangesShortsNews

Jan 27, 2022

06:40AM EST Barclays Maintains Equal-Weight on Icon, Lowers Price Target to $285 Benzinga

Jan 12, 2022

07:29AM EST ICON plc, (ICLR) said, for the full year 2022, revenue is expected to be in the range of $7.77 - $8.05 billion, representing growth of 43 - 46% and adjusted earnings per share in the range of $11.55 - $11.95, growth of 21 - 23%. RTTNews

07:08AM EST ICON Reaffirms 2021 Adj. EPS In Range Of $9.55 - $9.75; Revenue Of $5.43 Bln - $5.53 Bln RTTNews

07:07AM EST ICON Sees FY22 Adj. EPS $11.55-$11.95 vs $11.51 Est., Sales $7.77B-$8.05B vs $7.91B Est. Benzinga

07:00AM EST ICON Issues Financial Guidance for Full Year 2022 Business Wire

Jan 5, 2022

04:15PM EST ICON plc to Present at the 40th Annual JP Morgan Healthcare Conference Business Wire

Dec 7, 2021

07:00AM EST ICON Named Best Contract Research Organisation in Latest String of Industry Awards Business Wire

Nov 22, 2021

08:00AM EST ICON Releases Environmental, Social and Governance Report Business Wire

Nov 5, 2021

05:00PM EDT ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference Business Wire

10:51AM EDT Barclays Maintains Equal-Weight on Icon, Raises Price Target to $315 Benzinga

09:45AM EDT Mizuho Maintains Buy on Icon, Raises Price Target to $315 Benzinga

Nov 3, 2021

06:48PM EDT ICON Sees FY21 Adj. EPS $9.55-$9.75 vs $9.16 Est., Sales $5.43B-$5.53B vs $5.41B Est. Benzinga

06:46PM EDT Icon Q3 EPS $2.55 Up From $1.72 YoY, Sales $1.87B Up From $701.73M YoY Benzinga

04:50PM EDT ICON Reports Third Quarter 2021 Results Business Wire

Sep 27, 2021

01:00PM EDT Expert Ratings For Icon Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 Benzinga

07:53AM EDT 10 Biggest Price Target Changes For Monday Benzinga

05:00AM EDT JP Morgan Upgrades Icon to Overweight, Raises Price Target to $320 Benzinga

Sep 22, 2021

04:09PM EDT The Tnaiste and Minister for Enterprise, Trade and Employment Reports ICON Wins 4M In R&D Support Administered Benzinga

Sep 14, 2021

12:38PM EDT Where Icon Stands With Analysts Benzinga

09:56AM EDT Jefferies Maintains Buy on Icon, Raises Price Target to $302 Benzinga

Sep 2, 2021

06:00AM EDT ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference Business Wire

Jul 26, 2021

03:38PM EDT Where Icon Stands With Analysts Benzinga

11:25AM EDT Deutsche Bank Maintains Hold on Icon, Raises Price Target to $234 Benzinga

11:19AM EDT UPDATE: Citigroup On Icon Buy Upgrade: Co. Exhibits Premium Fundamentals To Its Peers Yet Stock Trades At A Significant Discount To Peer Group And IQV In Particular, The Co.'s Closest Competitor Benzinga

11:16AM EDT UPDATE: Citigroup On Icon Buy Upgrade: Firm Believes Combination Of Icon With PRA Will Drive Significant Benefits From Scale, Improved Product Offerings, And Meaningful Cost Out Opportunities That Should Create Meaningful Synergies Over Next Several Years Benzinga

Jul 23, 2021

03:02PM EDT What 7 Analyst Ratings Have To Say About Icon Benzinga

11:38AM EDT Citigroup Upgrades Icon to Buy, Announces $260 Price Target Benzinga

08:03AM EDT Wells Fargo Maintains Overweight on Icon, Raises Price Target to $280 Benzinga

Jul 21, 2021

04:25PM EDT Icon Sees FY21 EPS $9.10-$9.50, Sales $5.3B-$5.5B Benzinga

04:24PM EDT Icon Q2 EPS $2.12 Beats $2.08 Estimate, Sales $871.15M Beat $856.70M Estimate Benzinga

04:15PM EDT ICON Reports Second Quarter 2021 Results Business Wire

10:48AM EDT Earnings Preview: Icon Benzinga

06:09AM EDT ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting RTTNews

Jul 20, 2021

08:09AM EDT Credit Suisse Maintains Outperform on Icon, Raises Price Target to $250 Benzinga

Jul 1, 2021

08:52AM EDT ICON Completes Acquisition Of PRA Health Sciences RTTNews

08:43AM EDT ICON acquisition creates world-leading healthcare intelligence and clinical research organisation Business Wire

Jun 28, 2021

06:08PM EDT DT Midstream Set to Join S&P MidCap 400 PR Newswire

Jun 18, 2021

10:47AM EDT Evergreen Therapeutics Announces Agreement With ICON Plc To Conduct Phase II Clinical Trial For COVID-19 Drug Candidate Benzinga

Jun 17, 2021

09:25AM EDT ICON Announces Pricing of Senior Secured Notes Business Wire

Jun 15, 2021

04:15PM EDT ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting Business Wire

Jun 14, 2021

08:05AM EDT ICON Plans Private Offering Of Senior Secured Notes RTTNews

07:59AM EDT ICON Announces Private Offering of Senior Secured Notes Business Wire

May 25, 2021

06:00AM EDT ICON plc to Present at the Jefferies Virtual Healthcare Conference and the William Blair 41st Growth Stock Conference Business Wire

May 5, 2021

06:30AM EDT ICON plc to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare Conference Business Wire

May 3, 2021

10:21AM EDT Mizuho Maintains Buy on Icon, Raises Price Target to $242 Benzinga

Apr 29, 2021

09:07AM EDT Credit Suisse Maintains Outperform on Icon, Raises Price Target to $245 Benzinga

08:48AM EDT Jefferies Maintains Buy on Icon, Raises Price Target to $267 Benzinga

Apr 28, 2021

04:25PM EDT Icon Raises FY21 Guidance: Sales From $3.2B-$3.3B To $3.4B-$3.5B vs $3.24B Estimate, Adj. EPS From $8.10-$8.50 To $8.40-$8.80 vs $8.31 Est. Benzinga

04:25PM EDT Icon Q1 Adj. EPS $2.06 Beats $1.97 Estimate, Sales $858.20M Beat $787.38M Estimate Benzinga

04:05PM EDT ICON Reports First Quarter 2021 Results Business Wire

Apr 1, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2021 Benzinga

06:36AM EDT Wells Fargo Upgrades Icon to Overweight, Announces $235 Price Target Benzinga

Mar 9, 2021

10:00AM EST ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum Business Wire

Mar 8, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021 Benzinga

05:45AM EST Baird Upgrades Icon to Outperform, Announces $215 Price Target Benzinga

Mar 3, 2021

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021 Benzinga

06:34AM EST Barclays Initiates Coverage On Icon with Equal-Weight Rating, Announces Price Target of $200 Benzinga

Mar 1, 2021

11:03PM EST Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PR Newswire

10:40AM EST UBS Upgrades Icon to Buy, Raises Price Target to $232 Benzinga

Feb 26, 2021

11:06AM EST Truist Securities Upgrades Icon to Buy, Announces $280 Price Target Benzinga

Feb 25, 2021

11:22AM EST Deutsche Bank Maintains Hold on Icon, Raises Price Target to $208 Benzinga

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

Feb 24, 2021

12:10PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PRA Health Sciences, Inc. (NASDAQ: PRAH)breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by ICON plc (NASDAQ: ICLR). GlobeNewswire Inc

11:20AM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GlobeNewswire Inc

10:44AM EST (PRAH): Johnson Fistel Investigates the Proposed Sale of PRA Health; Are PR Newswire

07:13AM EST ICON Scoops Up PRA Health Sciences In $12B Deal Benzinga

06:34AM EST Icon Sees FY21 EPS $8.10-$8.50 Vs. $7.94 Est., Sales $3.2B-$3.3B Vs. $3.16B Est. Benzinga

06:34AM EST Icon Q4 EPS $1.90 Beats $1.83 Estimate, Sales $760.20M Beat $751.01M Estimate Benzinga

06:25AM EST ICONplc Q4 EPS Increases By 4% To $1.90; Adj. EPS $1.90 Increase Of 4.0% RTTNews

06:12AM EST ICON To Acquire PRA Health Sciences For $12B In Cash And Stock, With Per Share Consideration Consisting Of $80 In Cash And 0.4125 Shares Of ICON Stock Benzinga

06:09AM EST ICON To Acquire PRA Health Sciences In Cash And Stock Transaction Valued At About $12 Bln RTTNews

06:01AM EST ICON Reports Fourth Quarter and Full Year 2020 Results Business Wire

06:01AM EST ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research Business Wire

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

10:16AM EST Earnings Preview: Icon Benzinga

Feb 16, 2021

07:44AM EST Cytocom Provides Update Regarding Its CYTO-200 Portfolio Of Clinical Programs RTTNews

07:34AM EST Cytocom And ICON Enter Global Contract Research Organization To 'manage its upcoming Phase 3 clinical trial for its lead drug candidate, CYTO-201, as a treatment for Crohn's disease.' Benzinga

07:31AM EST Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial PR Newswire

Feb 8, 2021

04:30AM EST ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support Business Wire

Jan 7, 2021

04:15PM EST ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference Business Wire

Nov 11, 2020

06:00AM EST ICON Releases First Environmental, Social and Governance Report Business Wire

Oct 30, 2020

07:01AM EDT ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference Business Wire

Oct 23, 2020

09:21AM EDT Truist Securities Maintains Hold on Icon, Raises Price Target to $205 Benzinga

07:25AM EDT Mizuho Maintains Buy on Icon, Raises Price Target to $217 Benzinga

Oct 22, 2020

08:51AM EDT Credit Suisse Maintains Outperform on Icon, Raises Price Target to $235 Benzinga

Oct 21, 2020

06:39PM EDT 16 Stocks Moving In Wednesday's After-Hours Session Benzinga

04:51PM EDT Recap: Icon Q3 Earnings Benzinga

04:26PM EDT ICON Narrows, Raises Lower End Of FY20 Adj. EPS Guidance From $6-$6.50 To $6.35-$6.50 vs $6.27 Estimate Benzinga

04:25PM EDT ICON Raises FY20 Sales Guidance From $2.65B-$2.75B To $2.75B-$2.81B vs $2.72B Estimate Benzinga

04:25PM EDT ICON Narrows, Raises Lower End Of FY20 Adj. EPS Guidance From $6-$6.50 To $6.35-$6.50 Benzinga

04:17PM EDT Icon Q3 EPS $1.72 Beats $1.53 Estimate, Sales $701.70M Beat $660.79M Estimate Benzinga

04:15PM EDT ICON Reports Third Quarter 2020 Results Business Wire

04:07AM EDT Earnings Scheduled For October 21, 2020 Benzinga

Oct 19, 2020

09:02AM EDT ICON Reports Biomedical Advanced Research and Development Authority (BARDA) Reselected Co. As Preferred Partner To Help Strengthen US Emergency Preparedness, Response Benzinga

09:00AM EDT BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response Business Wire

Oct 7, 2020

05:00AM EDT ICON Wins Best CRO at the Vaccine Industry Excellence Awards Business Wire

Sep 3, 2020

04:30AM EDT ICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric Approach Business Wire

Sep 2, 2020

07:00AM EDT ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference Business Wire

Aug 21, 2020

04:30AM EDT Forbes names ICON in list of Best Employers in America for Women Business Wire

Jul 28, 2020

11:22PM EDT Earnings Scheduled For July 22, 2020 Benzinga

Jul 27, 2020

10:48AM EDT UBS Maintains Neutral on Icon, Raises Price Target to $194 Benzinga

10:18AM EDT Mizuho Maintains Buy on Icon, Raises Price Target to $195 Benzinga

08:22AM EDT Deutsche Bank Maintains Hold on Icon, Raises Price Target to $170 Benzinga

Jul 24, 2020

03:25PM EDT Benzinga's Top Upgrades, Downgrades For July 24, 2020 Benzinga

11:47AM EDT B of A Securities Downgrades Icon to Neutral Benzinga

09:27AM EDT Jefferies Maintains Buy on Icon, Raises Price Target to $220 Benzinga

Jul 23, 2020

08:30AM EDT Credit Suisse Maintains Outperform on Icon, Raises Price Target to $205 Benzinga

Jul 22, 2020

04:20PM EDT ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting Business Wire

04:15PM EDT ICON Reports Second Quarter 2020 Results Business Wire

04:11AM EDT Earnings Scheduled For July 22, 2020 Benzinga

document.getElementById("Hp1Qt7").onerror = function(){this.style.display='none';}; .dark-mode .D7C1F2{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .D7C1F2{ color: #333333; background-color: white; border: 2px solid #333333; }ICLRIcon Plcstock NASDAQ

ICLR
Icon Plc
stock NASDAQ